Cargando…
Suicidal Behavior and Depression in Smoking Cessation Treatments
BACKGROUND: Two treatments for smoking cessation—varenicline and bupropion—carry Boxed Warnings from the U.S. Food and Drug Administration (FDA) about suicidal/self-injurious behavior and depression. However, some epidemiological studies report an increased risk in smoking or smoking cessation indep...
Autores principales: | Moore, Thomas J., Furberg, Curt D., Glenmullen, Joseph, Maltsberger, John T., Singh, Sonal |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3206890/ https://www.ncbi.nlm.nih.gov/pubmed/22073240 http://dx.doi.org/10.1371/journal.pone.0027016 |
Ejemplares similares
-
Prescription Drugs Associated with Reports of Violence Towards Others
por: Moore, Thomas J., et al.
Publicado: (2010) -
Are Smoking Cessation Treatments Associated with Suicidality Risk? An Overview
por: Penberthy, J. Kim, et al.
Publicado: (2016) -
Smoking cessation treatment and risk of depression, suicide, and self harm in the Clinical Practice Research Datalink: prospective cohort study
por: Thomas, Kyla H, et al.
Publicado: (2013) -
Behavioral Interventions Associated with Smoking Cessation in the Treatment of Tobacco Use
por: Roberts, Nicola J., et al.
Publicado: (2013) -
Menthol cigarettes and smoking cessation behavior
por: Hoffman, Allison C, et al.
Publicado: (2011)